FTI Consulting, Inc. announced it will release its third quarter 2026 financial results on October 29, before the New York market opens. The company will hold a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results, which will be available live online and replayed for 90 days. This update is important for investors tracking the firm's performance amid its global consulting operations. FTI Consulting generated $3.8 billion in revenue in fiscal 2025 and employs over 8,100 people worldwide.
FTI Consulting's upcoming Q3 2026 results release provides context for financial sector interest. For readers following US Financials on Pluang as of Oct 08, 2026 18:12 WIB: out of 85 stocks, 12 rose and 70 fell. ING traded at USD 33.06 with a -2.54% change and a typical hold time of 94 days. Banco Santander was at USD 13.32, down 2.49%, with 69% sell orders. Robinhood Markets stood at USD 106.85, down 2.43%, with 96% buy orders and a 75-day hold time.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
